Mangalam Medication & Organics bulk deal: Vijay Kedia sells 1.38 lakh shares price Rs 48 lakh
The opposite sellers included Neo Apex Enterprise LLP (Rs 27.6 lakh), Epitome Buying and selling and Investments (Rs 42 lakh) and Multiplier Share & Inventory Advisors Personal Restricted (Rs 44 lakh).
Shares of Mangalam Medication surged 5% at the moment to settle at Rs 35.18 on the NSE.
Additionally Learn: Ashish Kacholia picks up 2.9% stake in smallcap Adcounty Media. Inventory down 60% from peak
Mangalam Medication, a Gujarat-based firm, commenced its manufacturing of Lively Pharmaceutical Elements (APIs) and Intermediates in 1977. It has a multi-product manufacturing facility on two areas, and an in-house Analysis & Growth laboratory.
The share worth of Mangalam Medication has eroded by 69% prior to now 12 months. However the inventory has seen vital shopping for motion over the previous month with shares leaping practically 40%.
Regardless of the late rally, the corporate’s shares are buying and selling under their 50-day and 200-day easy shifting averages (SMAs) of Rs 39.6 and Rs 69.3, respectively, in response to Trendlyne knowledge.Additionally Learn: Ramkrishna Forgings bulk deal: Morgan Stanley buys shares price Rs 95 crore
The rally has pushed the counter right into a strongly overbought zone with Day’s MFI suggesting a stage round 90. A quantity above 70 is taken into account as overbought whereas under 30 is seen as oversold.
The corporate reported a consolidated web lack of Rs 7.4 crore within the quarter-ended September 30, 2025 in comparison with a revenue after tax (PAT) of Rs 2.7 crore within the 12 months in the past interval. The full income within the quarter underneath evaluate was reported at Rs 50 crore, down 38% from Rs 80 crore posted by the corporate within the corresponding quarter of the final monetary 12 months.
(Disclaimer: The suggestions, strategies, views, and opinions given by the specialists are their very own. These don’t symbolize the views of The Financial Instances.)
